DePuy Orthopaedics, owned by Johnson & Johnson, has issued a voluntary recall of its ASR hip implant devices. According to the company, the patient revision surgery rate is double that of the industry average. A new unpublished study from the National Joint Registry of England & Wales (NJR) discovered that one in eight patients who received the ASR hip implants required a second or revision surgery five years after they received the implant.
According to the DePuy site and several articles, patients experiencing DePuy ASR hip failures include one or more of the following symptoms:
- nerve damage
- tissue damage
- muscle damage
- limited mobility
- component loosening
- component misalignment/dislocation
- soft tissue masses/non-cancerous tumors
- fracture of the bone around site/weak bones
- metal sensitivity/metal contamination/increased metal levels in blood
In addition, because of the additional damage to bone and scar tissue from DePuy ASR hip failures, revision surgery is costly. Know your rights. Simmons Hanly Conroy can help.
If you or a loved one has been affected, contact the firm to speak with our understanding and experienced DePuy hip recall lawyers, led by named shareholders Paul Hanly and Jayne Conroy.
Who is at risk?
The risk of DePuy hip failures were especially high in women followed by patients whose femoral head (or ball) is smaller than 50mm. In addition, both implants were popular with younger patients because the devices were supposed to reduce the chance of dislocation.
The patients who reported problems in the first five years, and had revision surgery, reported a variety of symptoms. These symptoms included pain, swelling and problems walking. If your symptoms are persistent, it could be a sign of a more serious problem, such as:
- Loosening caused when the implant does not stay attached to the bone
- Fracture(s) where the bone around the implant may have broken
- Dislocation caused when the two parts of the implant that move against each other become misaligned
Learn more about Depuy Hip Implant lawsuits. Our pharmaceutical attorneys have experience across the country in leadership positions. In January 2011, Jayne Conroy was appointed by United States District Judge David Katz of the Northern District of Ohio to serve on the Plaintiffs’ Steering Committee in the DePuy ASR Artificial Hip Implant Recall multidistrict litigation. In January 2012, Ms. Conroy was appointed to the Plaintiffs’ Executive Committee, and Paul Hanly was appointed Chair of the Plaintiffs’ Discovery Committee by United States District Judge Ed Kinkeade of the Northern District of Texas in the DePuy Pinnacle Artifical Hip Implant Products Liability Litigation.
Shareholder Trent Miracle served on the Plaintiffs’ Steering Committee- In re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation. Attorney Eric Johnson was on the national multidistrict litigation discovery sub-committee involving the DePuy Pinnacle System metal-on-metal hip implant. Of Counsel Sanford Smokler and Attorney Laura Singletary also have experience involving DePuy Hip Implant Products federal litigation.
I am very pleased and had a wonderful experience with the firm. Would definitely use their services again.